Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

LS 2616

Known as: LS-2616, LS2616 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
The quinoline-3-carboxamide, Linomide, has been shown to possess potent immunomodulatory activity. We have evaluated the effect… Expand
  • figure 1
  • figure 2
Is this relevant?
1993
1993
The effects of the anti picornaviral drug WIN 54954 (5-(5-(2.6-dichloro-4-(4.5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-me thyl… Expand
Is this relevant?
1993
1993
Linomide (LS-2616, quinoline-3-carboxamide) is a synthetic immunomodulator that stimulates natural killer cell activity and… Expand
Is this relevant?
1989
1989
In the current study we examine parameters affecting the metastasis of ocular tumors of in vivo derived B16F10 melanoma. In C57BL… Expand
  • table 1
  • table 2
  • table 3
  • table 5
  • table 6
Is this relevant?
1988
1988
We have studied the effects of immunotherapy in coxsackievirus B3-induced myocarditis in male BALB/c mice. A single i.p… Expand
Is this relevant?
1987
1987
Spleen cells from mice treated with LS2616 display a highly increased response to the polyclonal T cell lectin ConA. The total… Expand
Is this relevant?
1986
1986
Autoimmune MRL/1 mice were treated with a recently developed substance with immunomodulating properties, LS-2616. Treatment was… Expand
Is this relevant?
1986
1986
Autoimmune (NZB X NZW) F1 female hybrid mice were treated with LS-2616, a recently developed substance with immunomodulating… Expand
Is this relevant?
1986
1986
The carboxamide-quinoline LS 2616 is a novel immunomodulator augmenting natural killer (NK) cell activity and T-lymphocyte… Expand
  • figure I
  • figure 3
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
1985
1985
The quinoline-3-carboxamide LS 2616 administered to mice in drinking water increased spontaneous cytotoxicity against YAC-1 cells… Expand
Is this relevant?